These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31881333)

  • 1. Junction Location Identifier (JuLI): Accurate Detection of DNA Fusions in Clinical Sequencing for Precision Oncology.
    Shin HT; Kim NKD; Yun JW; Lee B; Kyung S; Lee KW; Ryu D; Kim J; Bae JS; Park D; Choi YL; Lee SH; Ahn MJ; Park K; Park WY
    J Mol Diagn; 2020 Mar; 22(3):304-318. PubMed ID: 31881333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy.
    Hsiao SJ; Zehir A; Sireci AN; Aisner DL
    J Mol Diagn; 2019 Jul; 21(4):553-571. PubMed ID: 31075511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Applications of Next-Generation Sequencing in Precision Oncology.
    Karlovich CA; Williams PM
    Cancer J; 2019; 25(4):264-271. PubMed ID: 31335390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
    Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
    BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
    Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
    J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA.
    Supplee JG; Milan MSD; Lim LP; Potts KT; Sholl LM; Oxnard GR; Paweletz CP
    Lung Cancer; 2019 Aug; 134():96-99. PubMed ID: 31320002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome.
    Park K; Tran H; Eng KW; Ramazanoglu S; Marrero Rolon RM; Scognamiglio T; Borczuk A; Mosquera JM; Pan Q; Sboner A; Rubin MA; Elemento O; Rennert H; Fernandes H; Song W
    Arch Pathol Lab Med; 2020 Dec; 144(12):1535-1546. PubMed ID: 32045275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience.
    Lih CJ; Takebe N
    Curr Probl Cancer; 2017; 41(3):201-211. PubMed ID: 28625332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
    Sheikine Y; Kuo FC; Lindeman NI
    J Clin Oncol; 2017 Mar; 35(9):929-933. PubMed ID: 28297627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NAB2-STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing.
    Guseva NV; Tanas MR; Stence AA; Sompallae R; Schade JC; Bossler AD; Bellizzi AM; Ma D
    Cancer Genet; 2016; 209(7-8):303-12. PubMed ID: 27292373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analytical workflow for accurate variant discovery in highly divergent regions.
    Tian S; Yan H; Neuhauser C; Slager SL
    BMC Genomics; 2016 Sep; 17(1):703. PubMed ID: 27590916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing Assays.
    Sims DJ; Harrington RD; Polley EC; Forbes TD; Mehaffey MG; McGregor PM; Camalier CE; Harper KN; Bouk CH; Das B; Conley BA; Doroshow JH; Williams PM; Lih CJ
    J Mol Diagn; 2016 May; 18(3):336-349. PubMed ID: 27105923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection.
    Atkins A; Gupta P; Zhang BM; Tsai WS; Lucas J; Javey M; Vora A; Mei R
    Mol Diagn Ther; 2019 Aug; 23(4):521-535. PubMed ID: 31209714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics workflows for clinical applications in precision oncology.
    Jäger N
    Semin Cancer Biol; 2022 Sep; 84():103-112. PubMed ID: 33476720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Clinical Validation of a Large Fusion Gene Panel for Pediatric Cancers.
    Chang F; Lin F; Cao K; Surrey LF; Aplenc R; Bagatell R; Resnick AC; Santi M; Storm PB; Tasian SK; Waanders AJ; Hunger SP; Li MM
    J Mol Diagn; 2019 Sep; 21(5):873-883. PubMed ID: 31255796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations.
    Allegretti M; Fabi A; Buglioni S; Martayan A; Conti L; Pescarmona E; Ciliberto G; Giacomini P
    J Exp Clin Cancer Res; 2018 Mar; 37(1):47. PubMed ID: 29506529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ChimPipe: accurate detection of fusion genes and transcription-induced chimeras from RNA-seq data.
    Rodríguez-Martín B; Palumbo E; Marco-Sola S; Griebel T; Ribeca P; Alonso G; Rastrojo A; Aguado B; Guigó R; Djebali S
    BMC Genomics; 2017 Jan; 18(1):7. PubMed ID: 28049418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Implementation of MetaFusion for Accurate Cancer-Driving Fusion Detection from RNA Sequencing.
    Apostolides M; Li M; Arnoldo A; Ku M; Husić M; Ramani AK; Brudno M; Turinsky A; Hawkins C; Siddaway R
    J Mol Diagn; 2023 Dec; 25(12):921-931. PubMed ID: 37748705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.